SKLZ:NYSESkillz Inc. Analysis
Data as of 2026-06-19 - not real-time
$8.84
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Skillz Inc. (SKLZ) is trading near its 20‑day SMA (≈$9) with the 20‑day SMA still above the 50‑day and 200‑day averages, indicating an underlying bullish framework, yet the price sits just below that short‑term average. Momentum is mixed: RSI hovers around the mid‑50s, while the MACD histogram is negative and the signal line is deemed bearish, and volume is on a downtrend, suggesting short‑term pressure. The stock faces a wide support zone near $7.2 and resistance around $10.3, with 30‑day volatility exceeding 100% and a beta close to 2, underscoring high price swings.
Fundamentally, the company posts deep operating losses, negative margins, and a high debt‑to‑equity ratio (>120%), though it holds a solid cash buffer that exceeds its debt. No dividend is paid and earnings per share remain negative, while valuation multiples such as P/E are meaningless and the price‑to‑book hovers around 1.35. Recent news of a corporate name change adds a minor catalyst but does not materially alter the financial outlook.
Fundamentally, the company posts deep operating losses, negative margins, and a high debt‑to‑equity ratio (>120%), though it holds a solid cash buffer that exceeds its debt. No dividend is paid and earnings per share remain negative, while valuation multiples such as P/E are meaningless and the price‑to‑book hovers around 1.35. Recent news of a corporate name change adds a minor catalyst but does not materially alter the financial outlook.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bearish MACD histogram and decreasing volume
- Price sitting just below the 20‑day SMA
- High short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Underlying bullish SMA alignment
- Substantial cash cushion offsetting debt load
- Unclear path to profitability
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Persistent negative earnings and margins
- Potential upside if turnaround materializes
- Elevated beta and sector volatility
Key Metrics & Analysis
Financial Health
Revenue Growth32.90%
Profit Margin-57.48%
P/E Ratio-2.7
ROE-49.58%
ROA-12.50%
Debt/Equity126.28
P/B Ratio1.3
Op. Cash Flow$-64732000
Free Cash Flow$-33208124
Industry P/E16.7
Technical Analysis
TrendBullish
RSI55.2
Support$7.19
Resistance$10.25
MA 20$8.98
MA 50$7.08
MA 200$5.64
MACDBearish
VolumeDecreasing
Fear & Greed Index92.14
Valuation
Target Price$2.50
Upside/Downside-71.72%
GradeOvervalued
TypeValue
Risk Assessment
Beta1.95
Volatility100.91%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.